SMITHS FALLS, ON, Feb. 24, 2016 /CNW/ - Tweed Inc. ("Tweed",
"the Company"), wholly-owned subsidiary of Canopy Growth
Corporation ("Canopy Growth") (TSX.V:CGC) is please to announce
that it has received its license to sell cannabis oil products. At
noon tomorrow, the Company will be launching the sale of
high-quality 10:1 Cannabis Oils consisting of
GMO-free organic sunflower oil and high-quality CO2-extracted
cannabis oils.
Since its inception, Tweed has focused on producing an
industry-leading variety of cannabis products that meet the needs
of a diverse clientele. To date, that has meant growing a diverse
selection of strains to ensure that patients find the strain that
truly meets their personal needs. With 10:1 Cannabis
Oils, the Company will continue that focus and ensure that
patients can still find the strain that is right for them, this
time in a digestible format. Starting with popular offerings of
Argyle, Princeton and Birds Eye,
Tweed will introduce new strain-specific 10:1 Cannabis Oils
on an ongoing basis.
The name of the new product line, 10:1 Cannabis Oils
reflects the ratio that each 10 ml of oil will contain the
equivalent of 1g of the corresponding Tweed dried-flower
variety. 10:1 Cannabis Oils will be sold in 100 ml
bottles.
"Introducing this new product category to our customers will
undoubtedly come with a learning curve, and ease-of-use and
education was top-of-mind for us. Creating a simple,
universal equivalency factor between flower and oil was the logical
solution and a simple way to ensure customers can manage their
dosing confidently," said Mark
Zekulin, President, Tweed.
Tweed chose to balance 10:1 Cannabis Oils with organic,
non-genetically modified sunflower oil because it is versatile
enough to cook or bake with, hypoallergenic, and even good to
ingest on its own as it comes.
Coinciding with the launch of 10:1 Cannabis Oils, Tweed
and its sister company, Bedrocan Canada, are pleased to announce
the launch of a fund to support the delivery of education programs
on the responsible use of cannabis.
The companies will commit a combined $50,000 toward partnerships with leading
organizations committed to responsible use education. In
addition, Tweed and Bedrocan Canada will commit an additional
$1, for every bottle of
10:1 Cannabis Oils sold, to this fund.
"Along with the launch of oils, we know that customers,
healthcare practitioners, and education partners have a lot of
questions, and we need to start building the resources to answer
those questions using a systematic, Canada-wide approach," said Bruce Linton, CEO of Canopy Growth. "As we move
towards a non-medical consumer market, education on responsible use
of cannabis will become all the more important, and as responsible
companies we need to get out ahead of that curve."
Strain-specific 10:1 Cannabis Oils will be for sale at
Tweed.com from $95 to $155 per
bottle, or from $76 to $124 for
patients qualifying for Tweed's Compassionate Pricing
program.
Here's to Future Oils.
About Tweed Inc.
Tweed Inc. is a Canadian company
licensed under the Marihuana for Medical Purposes
Regulations to produce and sell marijuana to authorized
medical customers. Tweed strives to supply a wide selection of
marijuana, as diverse as the patients who trust the company with
their patronage. For more information
visit www.tweed.com
About Canopy Growth Corporation
Canopy
is Canada's first publicly traded medical marijuana
company and the first geographically diversified producer with
multiple licenses under the Marihuana for Medical Purposes
Regulations.
Through its wholly owned subsidiaries, Tweed Inc., Tweed Farms
Inc. and Bedrocan Canada Inc., Canopy operates several
state-of-the-art production facilities in Ontario and
distributes marijuana across the country to Canadian patients
managing a host of medical conditions.
Canopy is dedicated to educating healthcare practitioners,
providing consistent access to high quality medication, and
furthering the public's understanding of how marijuana is used for
medical purposes.
Notice regarding Forward-Looking Statements
This news
release contains forward-looking statements. Often, but not
always, forward-looking statements can be identified by the use of
words such as "plans", "expects" or "does not expect", "is
expected", "estimates", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases
or state that certain actions, events or results "may", "could",
"would", "might" or "will" be taken, occur or be achieved.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance or achievements of the Company or any of its
subsidiaries to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements.
Although Canopy Growth Corporation has attempted to identify
important factors that could cause actual actions, events or
results to differ materially from those described in
forward-looking statements, there may be other factors that cause
actions, events or results not to be as anticipated, estimated or
intended. Readers should not place undue reliance on
forward-looking statements. The factors identified above are not
intended to represent a complete list of the factors that could
affect the Company or any of its subsidiaries. The forward-looking
statements included in this news release are made as of the date of
this news release and Canopy Growth Corporation does not undertake
an obligation to publicly update such forward-looking statements to
reflect new information, subsequent events or otherwise unless
required by applicable securities legislation.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
SOURCE Canopy Growth Corporation